All results
67 results for stronger study
-
Fluoxetine in MSK Trauma Patients
Musculoskeletal trauma is one of the leading causes of disability in the United States and its negative quality of life impact extends beyond that of physical…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid
This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)
The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
DOTS (20-0002)
This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Vasomune AV001-004
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Ne
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with…
- Ages
- N/A - 21 Years
- Sexes
- All
-
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adol
This phase III trial compares hematopoietic (stem) cell transplantation (HCT) using mismatched related donors (haploidentical [haplo]) versus matched unrelated…
- Ages
- 6 Months - 21 Years
- Sexes
- All
-
TREAT-MS
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has…
- Ages
- 18 Years - 60 Years
- Sexes
- All
-
Compare Chemo Before and After Surgery vs After Surgery Alone for the TX of Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization…
- Ages
- 35 Years - 100 Years
- Sexes
- All